D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
AVDL Avadel Pharmaceuticals
- 7.610
- -0.300-3.79%
Close Mar 10 16:00 ET
- 7.820
- +0.210+2.76%
Pre 06:29 ET
735.35MMarket Cap-14.92P/E (TTM)
7.990High7.460Low1.25MVolume7.800Open7.910Pre Close9.61MTurnover1.47%Turnover RatioLossP/E (Static)96.63MShares19.09052wk High9.96P/B645.41MFloat Cap7.39052wk Low--Dividend TTM84.81MShs Float43.600Historical High--Div YieldTTM6.70%Amplitude0.710Historical Low7.688Avg Price1Lot Size
About Avadel Pharmaceuticals Company
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Company Profile
SymbolAVDL
Company NameAvadel Pharmaceuticals
Listing DateJun 6, 1996
Issue Price10.39
Founded2015
CEOMr. Gregory J. Divis
MarketNASDAQ
Employees188
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code02
Phone353-1-901-5201
Websitehttp://www.avadel.com
Company Executives
- Name
- Position
- Salary
- Gregory J. Divis
- Director and Chief Executive Officer
- 985.20K
- Thomas S. Mchugh
- Chief Financial Officer and Principal Accounting Officer
- 663.14K
- Geoffrey M. Glass
- Non-Executive Chairman of the Board
- 482.34K
- Linda S. Palczuk
- Independent Director
- 452.34K
- Dr. Mark A. Mccamish, M.D.,PhD
- Independent Director
- 449.84K
- Dr. Eric J. Ende, M.B.A.,M.D.
- Independent Director
- 452.34K
- Peter J. Thornton
- Independent Director
- 459.84K
- Dr. Naseem S Amin, M.D.
- Independent Director
- --
- Jerad G. Seurer
- General Counsel and Corporate Secretary
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.